Avantax Planning Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
4,892
-350
-7% -$19K 0.01% 438
2026
Q1
$329K Buy
5,242
+201
+4% +$16.1K 0.01% 336
2025
Q4
$481K Sell
5,041
-44
-0.9% -$4.31K 0.01% 278
2025
Q3
$496K Buy
5,085
+290
+6% +$30K 0.01% 269
2025
Q2
$515K Hold
4,795
0.02% 263
2025
Q1
$484K Buy
4,795
+33
+0.7% +$3.32K 0.02% 264
2024
Q4
$425K Hold
4,762
0.02% 281
2024
Q3
$399K Sell
4,762
-56
-1% -$4.41K 0.01% 290
2024
Q2
$371K Sell
4,818
-93
-2% -$6.81K 0.01% 328
2024
Q1
$336K Buy
+4,911
New +$316K 0.01% 343
2020
Q1
Sell
-5,344
Closed -$242K 274
2019
Q4
$242K Sell
5,344
-177
-3% -$7.41K 0.01% 263
2019
Q3
$225K Buy
5,521
+80
+1% +$3.39K 0.01% 279
2019
Q2
$232K Buy
5,441
+38
+0.7% +$1.46K 0.02% 272
2019
Q1
$207K Buy
5,403
+3,403
+170% +$130K 0.01% 276
2018
Q4
$71K Sell
2,000
-2,848
-59% -$103K 0.01% 265
2018
Q3
$187K Buy
+4,848
New +$169K 0.02% 247
2018
Q2
Sell
-7,121
Closed -$197K 408
2018
Q1
$197K Buy
+7,121
New +$194K 0.02% 294
2017
Q4
Sell
-7,044
Closed -$205K 317
2017
Q3
$205K Buy
+7,044
New +$195K 0.02% 353

Other funds holding BSX

Avantax Planning Partners's BSX Position: Q2 2026 in Review

Avantax Planning Partners reduced its Boston Scientific (BSX) stake by 6.7% in Q2 2026, selling an estimated $19K and leaving 4,892 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #438.

Avantax Planning Partners first reported a position in BSX in Q3 2017 and has held it in 18 quarters since. The position peaked at $515K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Avantax Planning Partners held 4,892 shares of Boston Scientific worth $209K as of Q2 2026.
  • Avantax Planning Partners sold 350 Boston Scientific shares in Q2 2026, an estimated $19K.
  • Boston Scientific made up 0.01% of Avantax Planning Partners's portfolio in Q2 2026, its #438 holding.
  • Avantax Planning Partners first reported a position in Boston Scientific in Q3 2017 and has held it in 18 quarters since.
  • Avantax Planning Partners's Boston Scientific position peaked at $515K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Avantax Planning Partners's 13F filing for Q2 2026, filed 28 Jul 2026.